Xing Z. Zhang

26 Yuancun Er Heng Road
Guangzhou, 510655, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 86 publications

Long-term results of multi-antigen stimulated cell therapy-I, alone or in combination with chemotherapy, as first-line maintenance therapy in advanced sarcoma: a multicenter, phase 1 trial.

Long-term results of multi-antigen stimulated cell therapy-I, alone or in combination with chemotherapy, as first-line maintenance therapy in advanced sarcoma: a multicenter, phase 1 trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 08, 2026

Surufatinib plus toripalimab for patients with advanced solid tumors and disease progression after prior immunotherapy: an open-label multi-cohort phase 2 trial.

Surufatinib plus toripalimab for patients with advanced solid tumors and disease progression after prior immunotherapy: an open-label multi-cohort phase 2 trial.

Journal: Cancer immunology, immunotherapy : CII

Published: February 10, 2026

Brigimadlin Versus Doxorubicin in Advanced Dedifferentiated Liposarcoma: Efficacy, Safety and Translational Data from Brightline-1, a Randomized Phase 2/3 Trial.

Brigimadlin Versus Doxorubicin in Advanced Dedifferentiated Liposarcoma: Efficacy, Safety and Translational Data from Brightline-1, a Randomized Phase 2/3 Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: February 04, 2026

Global, regional, and national burden of diabetes mellitus type 2-related chronic kidney disease from 1990 to 2021 and projections to 2040.

Global, regional, and national burden of diabetes mellitus type 2-related chronic kidney disease from 1990 to 2021 and projections to 2040.

Journal: Journal of family medicine and primary care

Published: February 02, 2026

Evaluating the impact of artificial intelligence development on urban resilience: Evidence from Chinese cities.

Evaluating the impact of artificial intelligence development on urban resilience: Evidence from Chinese cities.

Journal: iScience

Published: August 29, 2025

Beyond Narrative Relief: Exploring the Impacts of Lacking Feedback and Perceived Cyber-Ostracism Based on the Temporal Need-Threat Model.

Beyond Narrative Relief: Exploring the Impacts of Lacking Feedback and Perceived Cyber-Ostracism Based on the Temporal Need-Threat Model.

Journal: Health communication

Published: March 31, 2025

Comparison of Transoral Endoscopic Thyroidectomy via the Vestibular Approach and Conventional Open Thyroidectomy for Papillary Thyroid Carcinoma: A Propensity Score-Matched Analysis.

Comparison of Transoral Endoscopic Thyroidectomy via the Vestibular Approach and Conventional Open Thyroidectomy for Papillary Thyroid Carcinoma: A Propensity Score-Matched Analysis.

Journal: Annals of surgical oncology

Published: January 28, 2025

Characterization of the regulatory network and pathways in duodenum affecting chicken abdominal fat deposition.

Characterization of the regulatory network and pathways in duodenum affecting chicken abdominal fat deposition.

Journal: Poultry science

Published: August 27, 2024

Evaluating the impact of smart city construction on sewage treatment in China from a synergistic perspective.

Evaluating the impact of smart city construction on sewage treatment in China from a synergistic perspective.

Journal: Scientific reports

Published: August 18, 2024

Enhancing electrochemical reductive defluorination of PFASs using ZIF-67 modified cathode: Mechanistic insights and performance optimization.

Enhancing electrochemical reductive defluorination of PFASs using ZIF-67 modified cathode: Mechanistic insights and performance optimization.

Journal: Water research

Published: July 30, 2024

Efficacy and safety of surufatinib plus toripalimab in treatment-naive, PD-L1-positive, advanced or metastatic non-small-cell lung cancer and previously treated small-cell lung cancer: an open-label, single-arm, multicenter, multi-cohort phase II trial.

Efficacy and safety of surufatinib plus toripalimab in treatment-naive, PD-L1-positive, advanced or metastatic non-small-cell lung cancer and previously treated small-cell lung cancer: an open-label, single-arm, multicenter, multi-cohort phase II trial.

Journal: Cancer immunology, immunotherapy : CII

Published: July 03, 2024

Public opinion outweighs knowledge: A dual-process framework for understanding acceptance of genetic modification among scientists and laypeople.

Public opinion outweighs knowledge: A dual-process framework for understanding acceptance of genetic modification among scientists and laypeople.

Journal: Risk analysis : an official publication of the Society for Risk Analysis

Published: June 11, 2024

Showing 1-12 of 86

Last Updated: 09/26/2026